FibroGen (NASDAQ:FGEN – Get Free Report) was downgraded by analysts at Bank of America from a “neutral” rating to an “underperform” rating in a note issued to investors on Tuesday, MarketBeat Ratings reports. They presently have a $2.00 price target on the biopharmaceutical company’s stock, down from their prior price target of $4.00. Bank of […]
FibroGen, Inc. (NASDAQ:FGEN) Receives Average Recommendation of "Reduce" from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Scripps Research scientists have developed a new strategy for identifying small molecules that can change the function of proteins, offering a promising path for discovering targeted drugs.
By comparing how mirror image versions of small molecules impact clusters of proteins, Scripps Research scientists can identify potential new drug targets.
Mirror-Image Molecules Open New Route for Cancer Drug Discovery miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.